A new diagnostics procedure has been discovered to accurately detect early sings of Parkinson's disease according to its developers.
The test only requires a single drop of blood according to Robert Nagele Ph.D., professor of Medicine at the University of Medicine and Dentistry, New Jersey. The blood test is simple. It detects a specific protein produced by the body in response to Parkinson's disease suspected individuals.
About the Disease
Parkinson's disease affects nerve cells of the brain responsible for muscle movement and coordination. When these cells die, they explode. The debris are then cleaned by autoantibodies to clear that debris. symptoms include tremor, stiffness of the arms, legs and trunk, shaking, and slowness of movements. Diagnosing the disease meant doctors taking medical history and conducting a series of neurological tests.
But using a blood test should diagnose the disease in its earlier stages thus providing earlier treatment.
The new test looks for these autoantibodies circulating in the blood stream which is narrowed down from 100 to 10 autoantibodies. When these proteins rise at a certain level, this signals the occurrence of the disease.
To evaluate the test, Nagele and his team tested it on more than 150 blood samples.
The results proved to be very significant. The blood test identified 100 per cent accurate those who have the disease. This could mean that the new test can identify those with Parkinson's from those with other disease and from those who are healthy.
"It sounds feasible and probably worth pursuing," says M. Flint Beal, MD, the Anne Parrish Titzell professor of neurology and neuroscience at the Weill Medical College of Cornell University.
If available, Nagele states that the new blood test will cost up to $200.
The test only requires a single drop of blood according to Robert Nagele Ph.D., professor of Medicine at the University of Medicine and Dentistry, New Jersey. The blood test is simple. It detects a specific protein produced by the body in response to Parkinson's disease suspected individuals.
About the Disease
Parkinson's disease affects nerve cells of the brain responsible for muscle movement and coordination. When these cells die, they explode. The debris are then cleaned by autoantibodies to clear that debris. symptoms include tremor, stiffness of the arms, legs and trunk, shaking, and slowness of movements. Diagnosing the disease meant doctors taking medical history and conducting a series of neurological tests.
But using a blood test should diagnose the disease in its earlier stages thus providing earlier treatment.
The new test looks for these autoantibodies circulating in the blood stream which is narrowed down from 100 to 10 autoantibodies. When these proteins rise at a certain level, this signals the occurrence of the disease.
To evaluate the test, Nagele and his team tested it on more than 150 blood samples.
The results proved to be very significant. The blood test identified 100 per cent accurate those who have the disease. This could mean that the new test can identify those with Parkinson's from those with other disease and from those who are healthy."It sounds feasible and probably worth pursuing," says M. Flint Beal, MD, the Anne Parrish Titzell professor of neurology and neuroscience at the Weill Medical College of Cornell University.
If available, Nagele states that the new blood test will cost up to $200.
No comments:
Post a Comment